国际标准期刊号: E-2314-7326
P-2314-7334

神经传染病

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

The Administration of Nano Suspensions Containing Antiviral Agents from the Nose to the Brain is One Method of Treating Neuro-AIDS Patients

Aarti V Belgamwar

Intranasal drug delivery is one in all the battle areas of the analysis in targeting drug to the brain. Nose to brain drug delivery follows the exteroception pathway and supposedly proverbial to be a lot of economical to deliver neuro-therapeutics to the brain by circumventing the BBB and thereby increasing bioavailability of medicine within the brain. The advantage of this technique is non-invasiveness, speedy onset of action and helps to realize web site specific delivery. During this analysis work Nano suspension were ready victimization combination of antiretroviral agents for Neuro-AIDS treatment. Nano suspensions were ready by high-speed homogenization, wet edge and aggressive homogenization techniques. Formulations were analyzed by SEM, FTIR, and DSC. Morphology and stability analysis was done by analysing letter of the alphabet potential, particle size, and PDI. Ex-vivo diffusion study and histopathological analysis was performed victimization goat nasal tissue layer. air mass homogenization was found to be best technique for formulation of nanosuspension. Antiviral medicine may well be delivered with success by optimizing nasal dose type.